首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1548104

全球尼古丁替代療法市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Nicotine Replacement Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球尼古丁替代療法市場需求預計將從 2023 年的 703.1 億美元達到近 2,935.8 億美元的市場規模，2024-2032 年研究期間複合年成長率為 17.21%。

尼古丁替代療法（NRT）是 FDA 批准的第一種用於戒菸的藥物。尼古丁替代療法旨在減少嘗試戒菸期間經常出現的戒斷症狀，從而增加保持戒菸的可能性。尼古丁口香糖是第一個在 80 年代初推出的產品，隨後在 90 年代初推出尼古丁貼片，幾年後這兩種產品都成為非處方藥 (OTC)。然後透過處方引入了尼古丁鼻噴霧劑，在同年又推出了尼古丁吸入器，現在這兩種產品都可以在櫃檯購買。尼古丁長片/片劑被推出，後來，它們以藥丸或糖果狀片劑的形式出現，也有非處方藥可供選擇。任何人都可以在藥房、藥局和超市購買所有這些交付形式。

市場動態

NRT 市場的推動因素包括日益成長的戒菸願望、越來越多的製造商提供反吸菸活動以及戒菸產品的普及。其他因素，例如慢性阻塞性肺病（COPD）、氣喘、肺癌、氣喘、各種心臟和呼吸系統疾病病例的增加，以及對吸菸負面影響的認知不斷提高，也將支持預測期內的市場擴張。

該報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。

此外，這些工具還對全球尼古丁替代療法市場中的每個應用/產品領域進行了包容性評估。

市場區隔

整個尼古丁替代療法市場已細分為產品類型和配銷通路。該報告根據地理細分對這些子集進行了分析。這項研究將使行銷人員了解情況，並有助於確定產品或服務的目標族群。

按產品分類

尼古丁替代療法（吸入器、口香糖、經皮貼片、舌下片、含片、其他）
電子煙
加熱不燃燒煙草製品

按配銷通路

線上
離線
區域分析

本節涵蓋區域細分，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲尼古丁替代療法市場當前和未來的需求。此外，該報告重點關注所有主要地區對個別應用領域的需求。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。尼古丁替代療法市場的主要參與者包括 Cipla Inc.、輝瑞、Glenmark Pharmaceuticals Ltd.、Fertin Pharma、Philip Morris Products SA、英美菸草公司、日本菸草公司、帝國品牌公司、強生私人有限公司。本節包括競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：尼古丁替代療法公司的競爭格局

尼古丁替代療法市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Cipla Inc.

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Glenmark Pharmaceuticals Ltd.

公司概況
公司收入
產品
最新動態

Fertin Pharma

公司概況
公司收入
產品
最新動態

Philip Morris Products SA

公司概況
公司收入
產品
最新動態

British American Tobacco Plc

公司概況
公司收入
產品
最新動態

Japan Tobacco Inc.

公司概況
公司收入
產品
最新動態

Imperial Brands Plc

公司概況
公司收入
產品
最新動態

Johnson & Johnson Private Limited

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11211481

The global demand for Nicotine Replacement Therapy Market is presumed to reach the market size of nearly USD 293.58 Billion by 2032 from USD 70.31 Billion in 2023 with a CAGR of 17.21% under the study period 2024 - 2032.

Nicotine replacement therapy (NRT) is the first pharmacological drug that was approved by the FDA for smoking cessation. Nicotine replacement therapy aims to reduce withdrawal symptoms which are often experienced during an attempt to quit smoking and thus increase the probability of remaining abstinent. Nicotine gums were the first product that was introduced in the early '80s followed by the nicotine patch in the early '90s and both became available over the counter (OTC) after few years. Then nicotine nasal spray was introduced by prescription, followed by the nicotine inhaler in the same year and now both them are available over the counter. Nicotine longezes/tablets were introduced, later on, they come in pill or candy-like tablet and are also available OTC. All these forms of delivery can be purchased by anyone at pharmacies, drug stores, and supermarkets.

Market Dynamics

The market of NRT is driven by the growing desire to quit smoking and the rising number of manufacturers offering anti-smoking campaigns and penetration of smoking cessation products. Other factors like growing cases of chronic obstructive pulmonary disease (COPD), asthma, lung cancer, asthma, various cardiac and respiratory disease coupled with rising awareness regarding negative effects of smoking is also set to support the market expansion over the forecast period.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of nicotine replacement therapy.

Market Segmentation

The entire nicotine replacement therapy market has been sub-categorized into product type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others)
E-cigarettes
Heat-not-burn Tobacco Products

By Distribution Channel

Online
Offline
Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for nicotine replacement therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Nicotine Replacement Therapy market include Cipla Inc., Pfizer Inc., Glenmark Pharmaceuticals Ltd., Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Japan Tobacco Inc., Imperial Brands plc, Johnson & Johnson Private Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NICOTINE REPLACEMENT THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others) Historic and Forecast Sales By Regions
5.5. E-cigarettes Historic and Forecast Sales By Regions
5.6. Heat-not-burn tobacco products Historic and Forecast Sales By Regions

6. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data
6.3. Analysis By Distribution Channel
6.4. Online Historic and Forecast Sales By Regions
6.5. Offline Historic and Forecast Sales By Regions

7. GLOBAL NICOTINE REPLACEMENT THERAPY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE NICOTINE REPLACEMENT THERAPY COMPANIES

8.1. Nicotine Replacement Therapy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF NICOTINE REPLACEMENT THERAPY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Cipla Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Pfizer Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Glenmark Pharmaceuticals Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Fertin Pharma
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Philip Morris Products S.A.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. British American Tobacco Plc
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Japan Tobacco Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Imperial Brands Plc
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Johnson & Johnson Private Limited
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others) Market Sales By Geography (USD MN)
E-cigarettes Market Sales By Geography (USD MN)
Heat-not-burn tobacco products Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Online Market Sales By Geography (USD MN)
Offline Market Sales By Geography (USD MN)
Global Nicotine Replacement Therapy Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Nicotine Replacement Therapy Report
Market Research Process
Market Research Methodology
Global Nicotine Replacement Therapy Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Nicotine Replacement Therapy (Inhalers, Gum, Transdermal Patches, Sublingual Tablets, Lozenges, Others) Market Sales By Geography (USD MN)
E-cigarettes Market Sales By Geography (USD MN)
Heat-not-burn tobacco products Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Online Market Sales By Geography (USD MN)
Offline Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis